<DOC>
	<DOCNO>NCT00002007</DOCNO>
	<brief_summary>To evaluate safety repeat course sargramostim ( recombinant granulocyte-macrophage colony-stimulating factor ; GM-CSF ) administer subcutaneously patient HIV infection leukopenia . To determine administration GM-CSF prevent hematologic toxicity associate zidovudine ( AZT ) treatment patient pre-existing leukopenia . To assess clinical and/or virologic benefit administer alternate week GM-CSF AZT patient symptomatic HIV infection history cytologically confirm Pneumocystis carinii pneumonia ( PCP ) circulate absolute CD4 lymphocyte count le 200 cells/mm3 .</brief_summary>
	<brief_title>A Pilot Trial Evaluating Alternating Schedule Recombinant Human GM-CSF Azidothymidine Patients With HIV Infection Leukopenia</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Leukopenia</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Patients must : Serum antibody HIV without evidence HIV antigenemia . White blood cell ( WBC ) = &lt; 4500 cells/mm3 measure least 2 occasion separate minimum 1 week . Qualifying indication AZT therapy . Life expectancy = &gt; 6 month . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Current past history malignancy include Kaposi 's sarcoma . Excessive diarrhea significant malabsorption . If patient &gt; 10 percent weight loss within past 3 month , malabsorption evidence serum carotene &lt; 75 IU/ml , serum vitamin A &lt; 75 IU/ml , significant malabsorption 4 foulsmelling greasy stool per day criterion . Currently hospitalize hospitalize within last 4 week treatment opportunistic infection ( IO ) . Less 1 week since complete treatment Pneumocystis carinii pneumonia ( PCP ) . Active OI require systemic treatment . Evidence nutritional deficiency may contribute anemia and/or leukopenia . Concurrent Medication : Excluded within 4 week study entry : Zidovudine ( AZT ) . Other antiviral agent associate leukopenia . Investigational drug . Immunomodulators . Interferon . Steroids . Excluded within 8 week study entry : Ribavirin . Excluded within 4 month study entry : Suramin . Patients follow exclude : Current past history malignancy include Kaposi 's sarcoma . Excessive diarrhea significant malabsorption . Currently hospitalize hospitalize within last 4 week treatment opportunistic infection ( OI ) . Less 1 week since complete treatment Pneumocystis carinii pneumonia ( PCP ) . Evidence nutritional deficiency may contribute anemia and/or leukopenia . Prior Medication : Excluded : Prophylactic therapy Pneumocystis carinii pneumonia ( PCP ) may cause leukopenia . Risk Behavior : Excluded : Current drug alcohol abuser . Unprotected sexual contact activity may result reinfection HIV . Patients must willing refrain unprotected sexual contact activity may result reinfection HIV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 1990</verification_date>
	<keyword>Leukopenia</keyword>
	<keyword>Granulocyte-Macrophage Colony-Stimulating Factor</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Zidovudine</keyword>
</DOC>